Key result
Older age and increased left atrial diameter were independently associated with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy, with odds ratios of 1.714 and 1.631.
Why the study?
AF presents a treatment challenge in ATTR-CM, and there are few studies exclusively assessing factors associated with AF in these patients to guide early diagnosis and intervention.
What factors are associated with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy?
Cross-Sectional (n=273)
Yes
What factors are associated with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy?
Answers are grounded in this paper and cite their sources.
In patients with transthyretin amyloidosis cardiomyopathy, older age (≥70 years) and increased left atrial diameter (>45 mm) are significantly associated with the presence of atrial fibrillation.
Main findings of factors associated with atrial fibrillation in patients with ATTR-CM. • The incidence of atrial fibrillation is variable; in the current cohort of patients with ATTR-CM it was 25.2%. • The Val142Ile mutation was the most frequently identified. • There are few studies exclusively in patients with ATTR-CM and atrial fibrillation and their factors associated. • The increase in left atrial diameter and older age were factors associated with atrial fibrillation in these patients. Atrial fibrillation (AF) presents a treatment challenge in patients with amyloidosis cardiomyopathy, particularly in transthyretin amyloidosis cardiomyopathy (ATTR-CM). Identifying factors associated with AF is important for early diagnosis and intervention. This study aims to identify factors linked to AF in ATTR-CM patients. The REACT registry, a retrospective, multicenter cohort study, enrolled patients with TTR mutation or wild type. ATTR-CM diagnosis was based on echocardiography and pyrophosphate scintigraphy, with some cases confirmed by biopsy. Binary logistic regression and multivariate analysis were used, with ROC curve analysis determining optimal cutoff points for continuous variables. The study included 273 patients, mostly male (73.2 %), with a median age of 73 years. The ATTR variant was found in 67.3 % (165 patients), and Val142Ile was the most common variant (29.3 %). AF was present in 25.2 % (59 patients). Logistic regression revealed age (per 10-year increase) and left atrial diameter (per 5-mm increase) as predictors of AF, with odds ratios of 1.714 (p = 0.009) and 1.631 (p = 0.002), respectively. ROC curve analysis identified age ≥ 70 years and left atrium > 45 mm as optimal cutoff points (AUC 0.643 and 0.727). In the ATTR amyloidosis registry, older age and increased left atrium size are associated with AF. These findings may help in the early diagnosis and management of AF in ATTR-CM patients.
No takes yet. Share an insight, caveat, or question.
Romero et al. (2025) conducted a cross-sectional in Transthyretin amyloidosis cardiomyopathy (ATTR-CM) (n=273). Older age and increased left atrial diameter were independently associated with atrial fibrillation in patients with transthyretin amyloidosis cardiomyopathy, with odds ratios of 1.714 and 1.631.
Synapse has enriched 10 related papers. Consider them for comparative context: